Earth Science Tech, Inc. SEC filings ETST
Earth Science Tech, Inc. has 404 filings in SEC EDGAR's recent list, going back to Feb 1, 2012. Its latest annual report, Form 10-K, was filed on Jun 18, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (officer or director change). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 10-Q/A | Amended quarterly report | Feb 18, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Jul 29, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Feb 20, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Jul 27, 2023 | Jun 30, 2023 |
| 10-Q/A | Amended quarterly report | Mar 17, 2023 | Dec 31, 2022 |
| 10-Q/A | Amended quarterly report | Mar 8, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Feb 10, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | Apr 28, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Nov 22, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Sep 28, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | Feb 12, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 13, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 24, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Feb 14, 2020 | Dec 31, 2019 |
| 10-Q/A | Amended quarterly report | Nov 18, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Nov 14, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 19, 2019 | Jun 30, 2019 |
| 10-Q/A | Amended quarterly report | Feb 27, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Feb 19, 2019 | Dec 31, 2018 |
| 10-Q/A | Amended quarterly report | Nov 20, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Nov 19, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Sep 5, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | Jun 1, 2016 | Dec 31, 2015 |
| 10-Q/A | Amended quarterly report | May 23, 2016 | Sep 30, 2015 |
| 10-Q/A | Amended quarterly report | May 17, 2016 | Jun 30, 2015 |
| 10-Q | Quarterly report | Nov 19, 2015 | Sep 30, 2015 |
| 10-Q/A | Amended quarterly report | Oct 8, 2015 | Dec 31, 2014 |
| 10-Q/A | Amended quarterly report | Sep 23, 2015 | Sep 30, 2014 |
| 10-Q/A | Amended quarterly report | Sep 17, 2015 | Jun 30, 2014 |
| 10-Q | Quarterly report | Aug 19, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | Feb 23, 2015 | Dec 31, 2014 |
| 10-Q | Quarterly report | Nov 19, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 19, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | Feb 28, 2014 | Dec 31, 2013 |
| 10-Q | Quarterly report | Nov 14, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 5, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | Jan 10, 2013 | Dec 31, 2012 |
| 10-Q | Quarterly report | Oct 31, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Jul 23, 2012 | Jun 30, 2012 |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ETST (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1538495
- Former names
- Ultimate Novelty Sports Inc. (until Apr 17, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.